Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
San Antonio Breast Cancer Symposium 2024 provided multiple updates in the field of HER2-positive breast cancer, including novel treatments, new treatment regimens and more.See Healio’s highlights in H ...
Ares, CD&R and Neuberger Berman target retail apparel; Life science companies ripe for PE investment
In early January came news that Marquee Brands, which is backed by Neuberger Berman , acquired Laura Ashley, the iconic London-based brand that sells home furnishings and fashion items. The seller was ...
16h
Dealbreaker on MSNAstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M DealBy selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially ...
CD Bioparticles announces the launch of its new line of Cellulose Nanoparticles. NEW YORK, NY, UNITED STATES, February 21, 2025 /EINPresswire ...
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...
4h
News Medical on MSNNew human antibody shows promise for Ebola virus treatmentNew research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...
The NIH has lost two distinguished leaders as mass layoffs directed by the Trump administration hit federal health agencies.
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
After two days of record highs, the U.S. stock market saw a decline with major indices like the Dow Jones and Nasdaq posting losses. In such fluctuating conditions, investors often look for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results